Diphtheria Outbreak in Australia 2026
Diphtheria outbreak in Australia document the largest outbreak of this once-feared bacterial disease that the country has recorded since national surveillance began in 1991 — and a genuine public health emergency that prompted the Australian Chief Medical Officer, Professor Michael Kidd AO, to declare diphtheria a Communicable Disease Incident of National Significance on 22 May 2026. By that date, approximately 230 cases had been notified nationally, representing a ~30-fold increase compared with the equivalent period across the previous four years (2022–2025). The outbreak began to build as early as October 2025, but escalated sharply from February 2026 onward, spreading through remote and very remote Aboriginal and Torres Strait Islander communities across the Northern Territory, Western Australia, Queensland, and South Australia.
The most important headline statistic is also the one that most requires careful context: one person has died in this outbreak — a patient in a remote part of the Northern Territory — with autopsy confirmation of diphtheria as the cause of death still being processed at time of publication. This single death sits against a historical backdrop in which only four diphtheria-related deaths were recorded in Australia between 1999 and 2025, and before widespread vaccination, the disease killed around one in ten people with the respiratory form. The fact that an estimated 90% of 2026 cases have occurred in people who were already vaccinated is simultaneously reassuring — the vaccine has blunted severity — and alarming, because it demonstrates that vaccination, while highly protective against severe disease, does not reliably prevent carriage or transmission. As of 22 June 2026, NSW Health noted that the number of new cases nationally is currently declining, the first sign of epidemiological improvement since the outbreak began. This article compiles the latest, most current verified statistics from the Australian Centre for Disease Control (CDC), Communicable Diseases Network Australia, and state health authorities.
Interesting Facts About the 2026 Diphtheria Outbreak in Australia
| Fact | Detail |
|---|---|
| Total diphtheria cases notified in Australia (as of ~22 May 2026) | ~230 cases — largest outbreak since national records began in 1991 |
| Total diphtheria cases as of 11 May 2026 (Australian CDC epi report) | 194 cases (including 2 probable) |
| Times above the historical equivalent-period baseline (2022–2025) | ~29.8 to 30-fold increase |
| Declared emergency status | Communicable Disease Incident of National Significance — declared 22 May 2026 |
| Outbreak start date (first increase) | October 2025 — with a sharp acceleration from February 2026 |
| Deaths confirmed in the 2026 outbreak | 1 death — Northern Territory (autopsy pending at time of publication) |
| Deaths from diphtheria in Australia, 1999–2025 | 4 deaths total over 26 years |
| Proportion of cases in vaccinated individuals | ~90% — vaccine blunts severity, but does not prevent transmission |
| Cases classified as cutaneous (skin) diphtheria | ~70% of cases |
| Cases classified as respiratory diphtheria | ~30% of cases |
| Share of cases among Aboriginal and/or Torres Strait Islander people | ~91–94% of all cases |
| Share of locally acquired cases in remote/very remote areas | 81.8% |
| Share in outer regional areas | 15.1% |
| Hospitalisation rate among 2026 cases | 24.7% (48 of 194 cases as of 11 May 2026) |
| State/territory distribution (as of ~22 May 2026) | NT: 139, WA: 82, SA: 7, QLD: 3 |
| Emergency funding announced by the federal government | A$7.2 million (21 May 2026) |
| National DTP vaccination coverage — children aged 5 (Sept 2025) | 93.4% — but declining since peak in 2020 |
| DTP vaccination coverage — Aboriginal and Torres Strait Islander children aged 5 | 94.7% |
| Trend as of 22 June 2026 | Number of new cases nationally is currently declining |
| Most recent Australian CDC epidemiological update | 15 June 2026 |
Source: Australian Centre for Disease Control (CDC), “Diphtheria outbreak update” (cdc.gov.au, accessed June 2026); Australian CDC Epidemiological update, 12 May 2026; Australian CDC Epidemiological update, 15 June 2026; Department of Health and Aged Care, Chief Medical Officer’s Statement declaring diphtheria a Communicable Disease Incident of National Significance (22 May 2026); NSW Health, “Fact sheets — Northern and Central Australia Diphtheria Outbreak 2026” (22 June 2026); National Centre for Immunisation Research and Surveillance (NCIRS), “Australia is battling its worst diphtheria outbreak in decades” (22 May 2026); The Conversation/Medical Journal of Australia, same article (22 May 2026); Outbreak News Today, “Diphtheria in Australia 2026” (20 May 2026)
The facts table above captures a public health emergency that is both historically significant for Australia and deeply concentrated within a specific and already-vulnerable population. The ~30-fold increase over baseline is the single most arresting statistical feature of this outbreak: diphtheria had effectively become a near-invisible disease in Australia over the past quarter-century, with only occasional sporadic cases trickling through the national surveillance system. The 194 cases recorded by 11 May 2026 in the Australian CDC’s epidemiological report — itself nearly double the total annual case counts recorded in any previous year since 1991 — continued climbing to ~230 cases by 22 May, before showing the first signs of decline in late June. Whether this declining trend represents genuine epidemiological progress or a surveillance artifact will become clearer in subsequent Australian CDC weekly reports.
The single confirmed death, reported by Dr John Boffa of the Central Australian Aboriginal Congress and acknowledged by NT Health pending full autopsy confirmation, is being handled with appropriate scientific caution by Australian authorities. The last previously confirmed diphtheria-associated death in Australia occurred in 2018 and involved an unvaccinated adult with respiratory diphtheria — a detail that underscores how dramatically vaccination had suppressed diphtheria mortality in the preceding decades. The fact that the 2026 death involved a person in a remote part of the Northern Territory is consistent with the outbreak’s overall epidemiological profile, where geographic remoteness and its associated barriers to healthcare access represent some of the most significant risk-multipliers for severe disease outcomes.
Outbreak Distribution: Cases by State and Territory in 2026
Diphtheria Cases by Jurisdiction — Australia 2026 (as of ~22 May 2026)
──────────────────────────────────────────────────────────────────────
Northern Territory (NT) │████████████████████████████████████████ 139 cases (60.3%)
Western Australia (WA) │████████████████████████████░░░░░░░░░░░░ 82 cases (35.6%)
South Australia (SA) │████░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ 7 cases (3.0%)
Queensland (QLD) │██░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ 3 cases (1.3%)
NSW/VIC/ACT/TAS │░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ 0 cases
└────────────────────────────────────────────────────
(Source: Australian CDC outbreak update; Health.vic.gov.au;
NCIRS 22 May 2026; Outbreak News Today 20 May 2026)
| Jurisdiction | Cases (~22 May 2026) | Cases (11 May epi report) | Key Detail |
|---|---|---|---|
| Northern Territory | ~139 | 117 (60.3%) | Epicentre — includes Darwin and Alice Springs clusters |
| Western Australia | ~82 | 71 (36.6%) | Outbreak identified in Kimberley region from late December 2025 |
| South Australia | ~7 | 4 cases | Additional spread beyond NT/WA |
| Queensland | ~3 | 2 cases | Limited additional spread |
| New South Wales | 0 | 0 | NSW Health confirmed 0 cases as of 22 June 2026 |
| Victoria | 0 | 0 | health.vic.gov.au: “No cases have been identified in Victoria to date” |
| ACT / Tasmania | 0 | 0 | No cases reported |
| Geographic concentration | Remote/very remote | 81.8% of locally acquired cases | Outer regional: 15.1%; urban: small minority |
Source: NCIRS The Conversation/MJA (22 May 2026); Outbreak News Today (20 May 2026, citing Australian CDC 11 May report); health.vic.gov.au clinician alert; NSW Health diphtheria outbreak fact sheet (22 June 2026); WA Health diphtheria alert (June 2026)
The geographic distribution of the 2026 outbreak is one of its most defining and policy-relevant characteristics. With ~60% of all cases in the Northern Territory and ~36% in Western Australia, two jurisdictions that together contain the majority of Australia’s most remote Aboriginal and Torres Strait Islander communities, the outbreak’s footprint maps almost precisely onto the geography of entrenched socioeconomic disadvantage rather than simply following population density. The outbreak in WA was identified specifically in the Kimberley region from late December 2025 — a vast, sparsely populated area where access to primary healthcare is structurally challenging — and the NT cases similarly cluster around Darwin and Alice Springs, with a particular concentration in remote areas reachable only by air or unsealed road.
The complete absence of cases in NSW, Victoria, the ACT, and Tasmania as of late June 2026 is epidemiologically significant and reflects a combination of factors: the higher vaccination coverage rates in urban and suburban populations, the absence of the specific social and environmental conditions driving transmission in remote communities (overcrowding, skin infections, limited healthcare access), and the effectiveness of the immediate response measures undertaken by affected states and territories. However, Victoria’s clinician alert, still active as of publication, specifically notes that clinicians should “consider diphtheria in patients with compatible respiratory or cutaneous illness, particularly those with recent travel to, or contact with people from, affected Aboriginal and Torres Strait Islander communities” — a reminder that geographic containment, while real, cannot be assumed permanent in a highly mobile national population.
Who Is Affected: Demographics & Risk Factors in 2026
Diphtheria 2026 — Key Demographic & Risk Factor Profile (Australian CDC data)
──────────────────────────────────────────────────────────────────────────────
Cases in Aboriginal/Torres Strait Islander people │████████████████████████████████████████ 94%
Cases in vaccinated individuals │████████████████████████████████████████ ~90%
Cases in remote/very remote areas (locally acq.) │████████████████████████████████████░░░░ 81.8%
Cases in outer regional areas │████████░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ 15.1%
Cases hospitalised (to 11 May 2026) │█████████░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ 24.7%
└──────────────────────────────────────────
(Source: Australian CDC epi update 11 May 2026;
NCIRS; Department of Health CMO statement)
| Demographic / Risk Indicator | Figure |
|---|---|
| Aboriginal and Torres Strait Islander share of all 2026 cases | ~91–94% |
| Cases in vaccinated individuals | ~90% — vaccine prevents severity, not necessarily infection |
| Cases in remote/very remote areas (locally acquired) | 81.8% |
| Cases in outer regional areas | 15.1% |
| Hospitalisation rate | 24.7% (as of 11 May 2026) |
| Highest-risk groups (Australian CDC guidance) | Unvaccinated; last dose >10 years ago; Aboriginal/Torres Strait Islander people in affected areas |
| Adults at risk due to waning immunity | By middle age, only ~50% of adults maintain protective antibody levels if not boosted |
| Adults’ recommended booster interval (national advice) | Every 10 years from early 20s; every 5 years for Aboriginal/Torres Strait Islander people and healthcare workers in affected areas |
| Healthcare workers in affected areas | Identified as a high-risk occupational group; specific guidance issued |
| Pregnant women | Recommended DTP booster at 20 to 32 weeks of pregnancy |
| Contributing factors identified by authorities | Waning immunity, lower routine immunisation rates in some communities, higher prevalence of skin infections, overcrowding, limited healthcare access |
| National DTP vaccination coverage (children age 5, Sept 2025) | 93.4% overall; 94.7% Aboriginal and Torres Strait Islander — but declining since 2020 |
Source: Australian CDC Epidemiological update 12 May 2026; NCIRS “Australia is battling its worst diphtheria outbreak in decades” (22 May 2026); Department of Health CMO statement (22 May 2026); health.vic.gov.au clinician alert
The demographic profile of this outbreak is the single most important fact for understanding what is driving it — and it is inseparable from Australia’s broader history of health inequity affecting Aboriginal and Torres Strait Islander communities. With 91–94% of all cases occurring in Aboriginal and/or Torres Strait Islander people, the outbreak is not a generalised Australian public health emergency but a concentrated crisis within communities that are simultaneously experiencing higher rates of skin infections (which facilitate cutaneous diphtheria transmission and can transmit to respiratory diphtheria in close contacts), lower rates of timely vaccination booster uptake, and structural barriers to healthcare access including geographic remoteness and insufficient health service density in affected regions.
The waning immunity dynamic is perhaps the most technically significant risk factor, and it carries implications well beyond the communities currently most affected. NCIRS researchers confirmed that while more than 99% of babies who receive all scheduled DTP vaccinations develop adequate antibody levels, by middle age approximately only half of Australian adults maintain those protective levels if they have not received booster doses. The national advice of a DTP booster every 10 years from early adulthood, and the updated outbreak-specific guidance of every 5 years for Aboriginal and Torres Strait Islander people and healthcare workers in affected communities, directly addresses this waning immunity problem — but the declining vaccination rates nationally since the COVID-19 pandemic, which caused Australia’s childhood immunisation rate to drop to a five-year low in 2025 according to NCIRS, mean the underlying population immunity foundation is weaker than it has been in recent years even before accounting for booster gaps in adult populations.
Diphtheria Treatment & Response Statistics in Australia 2026
Diphtheria Treatment Hierarchy — Australian Guidelines 2026
──────────────────────────────────────────────────────────────────
First priority (all suspected cases) │ Antibiotics (erythromycin or penicillin)
Respiratory diphtheria specifically │ Diphtheria antitoxin (DAT) — critical intervention
Close contacts │ Preventive antibiotics + vaccination (if indicated)
Cutaneous diphtheria │ Wound management + antibiotics
All cases │ Immediate notification to local public health unit
Community-level response │ Vaccination drives, healthcare worker deployment
Emergency funding package (Aust. Govt, May 2026) │ A$7.2 million
└──────────────────────────────────────────
(Source: Aus CDC outbreak guidance; Dept Health;
Australian Immunisation Handbook)
| Treatment / Response Metric | Detail |
|---|---|
| Primary treatment — respiratory diphtheria | Diphtheria antitoxin (DAT) + antibiotics (erythromycin or penicillin) |
| Primary treatment — cutaneous diphtheria | Wound management + antibiotics; slower healing, can become chronic |
| Preventive treatment for close contacts | Preventive antibiotics + vaccination/booster if indicated |
| Emergency government funding (21 May 2026) | A$7.2 million — largest diphtheria response package in Australian history |
| Funding breakdown | A$5.2 million to National Critical Care and Trauma Response Centre (NCCTRC) in collaboration with NT Government and Aboriginal Community Controlled health sector |
| Funding priorities | Increase vaccination, strengthen health workforce, improve antibiotic access, support local outreach |
| National guidance published | Australian CDC developed national diphtheria outbreak management guidance in collaboration with CDNA (Communicable Diseases Network Australia) — urgently produced |
| Legal notification requirement | Diphtheria is a nationally notifiable disease — suspected cases must be reported immediately by phone to local Public Health Units |
| Key government website for up-to-date case numbers | National Notifiable Diseases Surveillance System (NNDSS) and Australian CDC weekly epidemiology reports |
| Outbreak immunisation schedules | NT Health and WA Health both released outbreak-specific immunisation schedules for people living and working in affected communities |
| Treatment success rate (current outbreak) | Most cases mild — explicitly noted by the Australian CDC and the Chief Medical Officer |
| Untreated respiratory diphtheria mortality rate (historical, pre-vaccine) | ~10% |
Source: Department of Health and Aged Care, Chief Medical Officer’s Statement (22 May 2026); Australian CDC outbreak update; NCIRS (22 May 2026); Australian Immunisation Handbook; health.vic.gov.au clinician alert; health.wa.gov.au diphtheria alert (June 2026)
The treatment and response data confirms that Australia’s public health system has mobilised at a scale befitting the outbreak’s national significance declaration. The A$7.2 million emergency funding package announced by Health Minister Mark Butler on 21 May 2026 is the largest diphtheria-specific response investment in Australian history, reflecting both the severity of the outbreak and a deliberate political decision to front-load resources into Aboriginal Community Controlled health services rather than relying solely on government-run facilities — a lesson drawn from multiple previous outbreak responses in remote communities where community-controlled services have proven more effective at rapid, trusted outreach. The A$5.2 million directed through the National Critical Care and Trauma Response Centre (NCCTRC) in partnership with the NT Government and Aboriginal Community Controlled health sector is specifically aimed at deploying additional health workforce capacity into the most affected areas.
The clinical picture is more reassuring than the headline case numbers might initially suggest: the Australian CDC and Chief Medical Officer Professor Michael Kidd have both explicitly noted that “most reported cases in this outbreak have been mild,” a consequence directly attributable to the protective effect of prior vaccination. Even partial immunity — such as a vaccinated adult whose antibody levels have waned — typically results in a milder disease course than seen in unvaccinated individuals, a pattern borne out in the 24.7% hospitalisation rate (just under one in four cases) and in the single death among more than 230 notified cases. The declining new case trend confirmed by NSW Health as of 22 June 2026 provides cautious reason for optimism that the emergency measures are beginning to have effect — though public health authorities have been equally cautious about declaring success prematurely in an outbreak that had already surprised them with its speed and scale.
Disclaimer: The data research report we present here is based on information found from various sources. We are not liable for any financial loss, errors, or damages of any kind that may result from the use of the information herein. We acknowledge that though we try to report accurately, we cannot verify the absolute facts of everything that has been represented.
